Histogen to Present at the HC Wainwright 22nd Annual Global Investment Conference
September 01 2020 - 4:15PM
Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company
focused on developing potential first-in-class restorative
therapeutics that ignite the body’s natural process to repair and
maintain healthy biological function, today announced that Richard
W. Pascoe, President and Chief Executive Officer of Histogen, will
present at the HC Wainwright 22nd Annual Global Investment
Conference. The virtual presentation is scheduled for
Tuesday, September 15, 2020 at 11:30 a.m. Eastern Time.
Presentation Details Date: Tuesday September
15, 2020 Time: 11:30 a.m. Eastern Time (8:30 a.m. Pacific Time)
Live Webcast
Link: https://wsw.com/webcast/hcw7/hsto/1625710
For those not available to listen to the live broadcast, a
replay will be archived for 90 days and available through the
Investors page on www.histogen.com.
About Histogen Inc.
Histogen Inc. is a clinical-stage therapeutics company focused
on developing potential first-in-class restorative therapeutics
that ignite the body’s natural process to repair and maintain
healthy biological function. Histogen’s innovative technology
platform utilizes cell conditioned media and extracellular matrix
materials produced by hypoxia-induced multipotent cells. Histogen’s
proprietary, reproducible manufacturing process provides targeted
solutions across a broad range of therapeutic indications including
hair growth, dermal rejuvenation, joint cartilage regeneration and
spinal disk repair. For more information, please
visit www.histogen.com.
CONTACT:
Susan A. KnudsonExecutive Vice President & CFO Histogen Inc.
ir@histogen.com
Histogen (NASDAQ:HSTO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Histogen (NASDAQ:HSTO)
Historical Stock Chart
From Sep 2023 to Sep 2024